| Primary Care Of Shelton Llc | |
|
555 Bridgeport Ave Shelton CT 06484-4749 | |
| (203) 225-0506 | |
| Not Available |
| Full Name | Primary Care Of Shelton Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 555 Bridgeport Ave, Shelton, Connecticut |
| Authorized Official Name and Position | Bardia Asgari (CEO) |
| Authorized Official Contact | 2032250506 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Primary Care Of Shelton Llc 555 Bridgeport Ave Shelton CT 06484-4749 Ph: (203) 225-0506 | Primary Care Of Shelton Llc 555 Bridgeport Ave Shelton CT 06484-4749 Ph: (203) 225-0506 |
| NPI Number | 1700927720 |
|---|---|
| Provider Enumeration Date | 02/11/2007 |
| Last Update Date | 09/15/2008 |
| Medicare PECOS PAC ID | 0840394292 |
|---|---|
| Medicare Enrollment ID | O20070326000059 |
News Archive
The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their esophagus, called esophageal atresia.
Clinicians should take caution when diagnosing a child who has a high fever and whose tests show evidence of adenovirus, and not assume the virus is responsible for Kawasaki-like symptoms. According to a new study from Nationwide Children's Hospital appearing in Clinical Infectious Diseases, adenovirus detection is not uncommon among children with Kawasaki disease.
Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control.
Close on the heels of a large-scale clinical trial just underway to confirm that the female hormone estriol combats the effects of multiple sclerosis (MS) in women, a just completed pilot study at UCLA now shows promise for the use of testosterone to combat its effects in men.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700927720 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 038488 (Connecticut) | Primary |
| Provider Name | Bardia Asgari |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1811938533 PECOS PAC ID: 2163526260 Enrollment ID: I20070329000470 |
News Archive
The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their esophagus, called esophageal atresia.
Clinicians should take caution when diagnosing a child who has a high fever and whose tests show evidence of adenovirus, and not assume the virus is responsible for Kawasaki-like symptoms. According to a new study from Nationwide Children's Hospital appearing in Clinical Infectious Diseases, adenovirus detection is not uncommon among children with Kawasaki disease.
Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control.
Close on the heels of a large-scale clinical trial just underway to confirm that the female hormone estriol combats the effects of multiple sclerosis (MS) in women, a just completed pilot study at UCLA now shows promise for the use of testosterone to combat its effects in men.
› Verified 7 days ago
News Archive
The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their esophagus, called esophageal atresia.
Clinicians should take caution when diagnosing a child who has a high fever and whose tests show evidence of adenovirus, and not assume the virus is responsible for Kawasaki-like symptoms. According to a new study from Nationwide Children's Hospital appearing in Clinical Infectious Diseases, adenovirus detection is not uncommon among children with Kawasaki disease.
Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control.
Close on the heels of a large-scale clinical trial just underway to confirm that the female hormone estriol combats the effects of multiple sclerosis (MS) in women, a just completed pilot study at UCLA now shows promise for the use of testosterone to combat its effects in men.
› Verified 7 days ago
Value Based Long Term Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5 Research Dr Ste 2, Shelton, CT 06484 Phone: 781-343-1475 | |
Revival Iv And Wellness Clinic Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 12 Progress Dr Ste 1d, Shelton, CT 06484 Phone: 475-314-3011 Fax: 475-314-3011 | |
John Farens Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 224 Leavenworth Rd, Shelton, CT 06484 Phone: 203-926-1206 Fax: 203-926-0413 | |
H And B Quality Medical Care Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2 Ivy Brook Rd Ste 120, Shelton, CT 06484 Phone: 860-754-7407 | |
Value Based Long Term Care B Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5 Research Dr Ste 2, Shelton, CT 06484 Phone: 203-567-5243 | |
Advanced Pain And Regenerative Medical Solutions Corp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10 Progress Dr, Shelton, CT 06484 Phone: 203-948-8127 | |
St. Vincents Urgent Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 15 Armstrong Rd, Shelton, CT 06484 Phone: 203-929-1109 |